Title:
Mysterious alarming mucormycosis: Anesthetic challenges in a series of four cases

dc.contributor.authorNeville Jf
dc.contributor.authorAbhinay Jayanthi
dc.contributor.authorReena
dc.contributor.authorAmrita Rath
dc.date.accessioned2026-02-07T10:58:57Z
dc.date.issued2022
dc.description.abstractThe sudden epidemic of mucormycosis amid COVID‑19 pandemic has significantly challenged our understanding of the disease while affecting the whole medical and surgical management. Overzealous use of steroids in the management of covid‑19 and uncontrolled diabetes mellitus has resulted in a tremendous rise in mucormycosis cases further burdening the already strained health care infrastructure and health care workers, especially the anesthesiologists.While working in a tertiary care institute of the country, we have been facing multiple challenges in its anesthetic management on a daily basis.This article is a case series involving four different patients who were operated for rhino‑orbito‑cerebral mucormycosis with a brief discussion on various aspects of this multisystem epidemic. © 2022 National Journal of Maxillofacial Surgery.
dc.identifier.doi10.4103/njms.njms_465_21
dc.identifier.issn9755950
dc.identifier.urihttps://doi.org/10.4103/njms.njms_465_21
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/40772
dc.publisherWolters Kluwer Medknow Publications
dc.subjectAmphotericin B
dc.subjectCOVID‑19
dc.subjectdiabetes mellitus
dc.subjectmucormycosis
dc.subjectrhino‑orbital‑cerebral mucormycosis
dc.subjectsteroids
dc.titleMysterious alarming mucormycosis: Anesthetic challenges in a series of four cases
dc.typePublication
dspace.entity.typeArticle

Files

Collections